London, UK, Sep. 2023 -- SpatialX Ltd, an AI cancer diagnostics company specializing in AI decision support models for histopathology, announced today that it has joined NVIDIA Inception, a program dedicated to nurturing startups revolutionizing industries with cutting-edge technology.

SpatialX leverages advanced AI-based models to analyze whole-slide images, utilizing proprietary deep learning workflows. These solutions enable pathologists and clinicians to efficiently assess and interpret imaging data, leading to quicker and more confident decision-making.

Membership in NVIDIA Inception provides SpatialX access to NVIDIA's technology and technical expertise, including the latest GPUs essential for handling extensive vision models like transformers and domain-specific models. This partnership will accelerate the delivery of top-tier AI solutions to SpatialX's customers and facilitate collaboration with industry-leading experts and companies.

"We are thrilled to join NVIDIA Inception. In collaboration with NVIDIA, we plan to bring the power of AI-driven innovation to pathologists and clinicians, taking a crucial step in the fight against cancer and improving patient outcomes," said Noor Shaker, CEO of SpatialX.